Guangzhou Trauer Biotechnology Co., Ltd. was founded in August 2002. As a high-tech enterprise integrating R&D, production and sales, we possess core technologies for bioactive medical collagen materials, with a focus on bioactive collagen materials, medical devices and bio-skincare products.
As the pioneer of the collagen dressing industry in China, we hold the first medical device registration certificate for collagen dressings in China and have developed China’s NMPA Class III medical device collagen sponge. After more than 20 years of development, Trauer Biotech has become a leading enterprise in the domestic segment of medical bioactive collagen materials, and strives to become a global leader in medical collagen.
As a professional supplier of medical-grade bioactive collagen raw materials, Trauer Biotech has established a standardized quality management system and strict product standards. We have obtained ISO13485 and ISO22442 certifications, EU TSE-CEP certification, and US MAF submission. We provide compliant, high-quality collagen raw materials and customized solutions for global partners in medical devices, biopharmaceuticals, aesthetic medicine, functional skincare and other fields. We look forward to joining hands with global partners to deepen cooperation in raw material supply, joint R&D, technological breakthroughs and other dimensions, and jointly promote the global development of the medical collagen industry.
Trauer Biotech adheres to the path of independent innovation and has successively established a China R&D Center and a US International R&D Center. We have undertaken projects under the National 863 Program of China, been recognized as a national high-tech enterprise, and received numerous honors including Guangdong Top 100 Independent Brands, Guangzhou Private Leading Enterprise, National/Provincial-level Specialized, Sophisticated, Unique and New "Little Giant" Enterprise, and National Key Specialized, Sophisticated, Unique and New "Little Giant" Enterprise.








































































